agilon health, inc. Financing Receivable, Allowance for Credit Loss
agilon health, inc. (AGL) had Financing Receivable, Allowance for Credit Loss of $0 as of 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Balance Sheet › Assets
us-gaap:FinancingReceivableAllowanceForCreditLosses · last filed 2023-05-09
- 2023-03-31: Financing Receivable, Allowance for Credit Loss $0.00.
- 2022-12-31: Financing Receivable, Allowance for Credit Loss $0.00.
- 2022-09-30: Financing Receivable, Allowance for Credit Loss $0.00.
- 2022-06-30: Financing Receivable, Allowance for Credit Loss $0.00.
| Period end | Financing Receivable, Allowance for Credit Loss |
|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 |
| 2022-12-31 | $0.00 10-Q · filed 2023-05-09 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-03 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |